Abstract:Background Elevated inflammatory cytokines seen in multiple sclerosis (MS) promote cerebrovascular stress and provoke endothelial disturbances. Despite the high metabolic rate of neurons and their sensitivity to the local environmental milieu, the brain lacks a ‘conventional’ lymphatic system, which in peripheral tissues aids in clearance of metabolic wastes and immune cells. Recently changes in lymphatic‐venous biomarkers have been observed in human brain tissue and serum in MS. Whether and how these molecular features might contribute to clearance of fluid and debris remains unclear, but the transfer of lymphatic venous proteins from brain endothelial cells (‘BEC’) to MPs during neuroinflammation could represent a valuable marker and mediator of neurovascular stress. Objective We determined the individual and combined effects of pro‐inflammatory cytokines tumor necrosis factor‐α (TNF‐α) and interferon‐γ (IFN‐γ) on the expression levels of lymphatic‐venous biomarkers including lymphatic vessel endothelial hyaluronan receptor (LYVE‐1), Prospero Homeobox‐1 (Prox‐1), forkhead box C2 (FoxC2), vascular endothelial growth factor receptor‐3 (VEGFR‐3) and podoplanin in murine BEC as well as in microparticles (MPs) derived from these cells. Methods Murine BEC, bEnd.3, were treated with TNF‐α (20 ng/ml) and/or IFN‐γ (1000 U/ml) for 48 hours. The number of MPs shed from cells under different treatment conditions were analyzed using flow cytometry. Levels of lymphatic‐venous biomarker expressions were determined in both cells and MPs using western blotting. Expression patterns of these proteins were examined using immunocytochemistry. Fluorescently labeled BODIPY‐cholesterol was used to observe cholesterol partitioning of cellular membranes into MPs. Results Several lymphatic‐venous biomarkers were basally expressed by bEnd.3 cells and transferred into endothelial MPs following TNF‐α/IFN‐γ stimulation. IFN‐γ treatment caused a significant decrease of LYVE‐1 ( p <0.01), VEGFR‐3 ( p <0.01) as well as Prox‐1 ( p <0.01). TNF‐α significantly increased podoplanin ( p <0.05) and VEGFR‐3 ( p <0.05) levels in the cells. Following combined treatment MP LYVE‐1 increased significantly ( p <0.01) but decreased in cells ( p <0.05). Combined treatment also significantly decreased cellular Prox‐1 levels ( p <0.001). Combined stimulation also potently induced transfer of caveolin‐1 into MPs, measured as a significant decrease in cells ( p <0.05) and increase in MPs ( p <0.05). Similarly, TNF‐α/IFN‐γ stimulated bEnd.3 cells to shed membrane cholesterol, (measured by BODIPY‐cholesterol) consistent with endothelial MP identity as caveolae released by cytokine‐activated BEC. Conclusion These findings show that pro‐inflammatory cytokines alter lymphatic‐venous proteins as well as caveolar partitioning from BEC into MPs; such events may represent important indices of neurovascular/neurodegenerative disease. Support or Funding Information Supported by the Annette Funicello Research Fund for Neurologic Research and the Department of Neurology, Louisiana State Univeristy Health Sciences Center ‐ Shreveport

Immunocompetence of human microvascular brain endothelial cells: cytokine regulation of IL-1β, MCP-1, IL-10, sICAM-1 and sVCAM-1

ECIS technology reveals that monocytes isolated by CD14+ve selection mediate greater loss of BBB integrity than untouched monocytes, which occurs to a greater extent with IL-1β activated endothelium in comparison to TNFα

Brain Endothelial Cells Segregate Lymphatic‐Venous Biomarkers into Microparticles Following Inflammatory Cytokine Stimulation

Systemic inflammation modulates the levels of EBI2 and 7α,25-OHC synthesizing (CH25H, CYP7B1) and degrading (HSD3B7) enzymes in brain microvascular cells

Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple Sclerosis.

IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease

Visualization of chemokine binding sites on human brain microvessels

The functional and inflammatory response of brain endothelial cells to Toll-Like Receptor agonists

HSV-1 and Cellular miRNAs in CSF-Derived Exosomes as Diagnostically Relevant Biomarkers for Neuroinflammation

Brain region-specific microglial and astrocytic activation in response to systemic lipopolysaccharides exposure

Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins.

Vascular Endothelial Growth Factor secretion and immunosuppression are distinct potency mechanisms of Human Bone Marrow Mesenchymal Stromal Cells

Characterisation of ReNcells CX and VM stimulated with interleukin-1β and lipopolysaccharide

Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5

The role of neutrophil granulocytes in immune-to-brain communication

Endothelial Cell-Derived Soluble CD200 Determines the Ability of Immune Cells to Cross the Blood–Brain Barrier

Inflammatory biomarkers in blood of patients with acute brain ischemia

Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement

Interleukin-1 promotes autoimmune neuroinflammation by suppressing endothelial heme oxygenase-1 at the blood–brain barrier

Investigations on the Ability of the Insular Cortex to Process Peripheral Immunosuppression

Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha.